Drug Executive Collapses During White House Press Conference
During a press event in the Oval Office, a drug executive fainted while President Donald Trump was announcing a deal to lower prices on obesity medications.
Incident Details
The event involved drugmakers Eli Lilly and Novo Nordisk discussing a new agreement to expand coverage and reduce costs for their obesity treatments, Zepbound and Wegovy.
David Ricks, CEO of Eli Lilly, was speaking when he noticed the executive collapse and asked,
“Are you okay? Gordon, are you okay?”
Response and Aftermath
The individual was identified as Gordon Findlay, Global Brand Director at Novo Nordisk. As he collapsed, Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, quickly intervened. The press was then asked to leave the room.
Health and Human Services Secretary was also present during the incident.
Press Conference Resumption
Approximately 30 minutes later, the press conference resumed, and President Trump provided an update on Findlay's health.
President Trump said that the executive was recovering after the incident.
Author's Summary: During President Trump's announcement of a drug price deal, Novo Nordisk executive Gordon Findlay fainted in the Oval Office but received immediate help, and the event continued after a brief pause.